51995-99-4 Usage
General Description
Dehydroespeletone is a natural chemical compound found in certain plant species, such as the Eucalyptus species. It is classified as a phloroglucinol derivative and is known for its anti-inflammatory and antioxidant properties. Dehydroespeletone has been studied for its potential pharmaceutical and medicinal applications, particularly in the treatment of inflammatory and oxidative stress-related diseases. It has shown promise in reducing inflammation and protecting against oxidative damage in various cellular and animal models. Further research is ongoing to determine its potential therapeutic effects and possible applications in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 51995-99-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,9,9 and 5 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 51995-99:
(7*5)+(6*1)+(5*9)+(4*9)+(3*5)+(2*9)+(1*9)=164
164 % 10 = 4
So 51995-99-4 is a valid CAS Registry Number.
51995-99-4Relevant articles and documents
Promiscuous substrate binding explains the enzymatic stereoand regiocontrolled synthesis of enantiopure hydroxy ketones and diols
Kurina-Sanz, Marcela,Bisogno, Fabricio R.,Lavandera, Ivan,Orden, Alejandro A.,Gotor, Vicente
supporting information; experimental part, p. 1842 - 1848 (2011/02/25)
Regio- and stereoselective reductions of several diketones to afford enantiopure hydroxy ketones or diols were accomplished using isolated alcohol dehydrogenases (ADHs). Results could be rationalised taking into account different (promiscuous) substrate-binding modes in the active site of the enzyme. Furthermore, interesting natural cyclic diketones were also reduced with high regio- and stereoselectivity. Some of the 1,2 and 1,3-diketones used in this study were reduced by employing a low excess of the hydrogen donor (2-propanol) due to the quasi-irreversibility of these ADH-catalysed processes. Thus, using lower quantities of co-substrate, scale-up could be easily achieved.
